FARALLON CAPITAL MANAGEMENT LLC

Q3 2023 13F-HR Detailed Holdings

Location
San Francisco, CA
Holdings as of
9/30/2023
Date filed
11/14/2023
Form type
13F-HR
Num holdings
159
Total value ($000)
$19,950,818
Net value change ($000)
+2,055,741 (11.5%)
New positions
31
Sold out positions
29
Turnover %
31.4%
Sector allocation + QoQ delta (equities-only)

Holdings broken out by other managers reported in the original SEC filing. View aggregated holdings

You are on the SEC detailed breakdown page. Rows are shown as reported in the filing (including other manager, discretion, and voting authority fields), and are not merged like the standard holdings view. Switch to aggregated holdings.

Snapshot: Change Analysis

Compared to Q2 2023
Methodology: sector metrics are equities-only; instrument mix chart is ex-options; options exposure is shown separately. Why this matters.
Top Adds (Value $000, Stocks/ETFs)
AIY 1,902,562 NEW
Horizon Therapeutics Public Ltd Co 770,128 NEW
CHTR 488,790 NEW
CBRE 333,876 NEW
MSFT 132,737 45.3%
CRM 101,388 24.7%
UNH 73,963 12.2%
EXEL 70,856 14.3%
VRTX 70,243 NEW
HUM 61,752 53.4%
Top Reduces (Value $000, Stocks/ETFs)
IQV -324,935 -37.4%
EFX -249,111 -100.0%
BIIB -172,077 -100.0%
XYZ -119,206 -53.5%
TMO -118,650 -18.3%
SHW -98,210 -26.9%
IVERIC bio, Inc. -96,080 -100.0%
BABA -81,075 -52.0%
V -71,683 -29.0%
HWM -70,726 -24.4%
Instrument mix + QoQ Δ (ex-options)
Derivatives reported exposure ($000): 3,719,076 (18.6% of total reported value)
How this table is calculated: SEC VALUE ($000) is used as reported. For derivatives (PUT/CALL/WARRANT/RIGHT), SEC value represents reported underlying exposure, not premium cash paid/received. Column % is bucket-based: non-options share is calculated inside non-option total, options share is calculated inside options total. Details.
Filter:
Instrument:
Issuer Name Ticker Sector Industry Class History Value ($000) % Shares Shares Δ Shares Δ% Value Δ ($000) Value Δ% Principal Option Type Discretion Other Manager Sole Shared None

Other Managers

Num Name File Number
1 Farallon Capital Europe LLP 028-11719